Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
JCO Oncology Practice
|
August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer Measure
Yashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
Annals of Surgical Oncology
|
January 23, 2024
Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks
Puneet Singh, Doreen Agnese, Miral Amin, et al.
Journal of the American College of Surgeons
|
May 17, 2023
Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial
Anna Weiss, Tianyu Li, Neelam V Desai, et al.
JCO Oncology Practice
|
May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)
Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
JAMA Oncology
|
December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial
Ann H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Annals of Surgical Oncology
|
November 13, 2024
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks
Puneet Singh, Doreen M Agnese, Miral Amin, et al.
Nature Medicine
|
February 7, 2025
Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial
Ethan Basch, Deborah Schrag, Jennifer Jansen, et al.
JAMA Oncology
|
August 21, 2025
Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial
Jennifer A Ligibel, Karla V Ballman, Linda McCall, et al.
JAMA
|
June 6, 2022
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial
Ethan Basch, Deborah Schrag, Sydney Henson, et al.
JAMA Oncology
|
January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial
Cynthia X Ma, Vera J Suman, Souzan Sanati, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
JCO Oncology Practice
|
August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer Measure
Yashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
Annals of Surgical Oncology
|
January 23, 2024
Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks
Puneet Singh, Doreen Agnese, Miral Amin, et al.
Journal of the American College of Surgeons
|
May 17, 2023
Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial
Anna Weiss, Tianyu Li, Neelam V Desai, et al.
JCO Oncology Practice
|
May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)
Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
JAMA Oncology
|
December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial
Ann H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Annals of Surgical Oncology
|
November 13, 2024
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks
Puneet Singh, Doreen M Agnese, Miral Amin, et al.
Nature Medicine
|
February 7, 2025
Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial
Ethan Basch, Deborah Schrag, Jennifer Jansen, et al.
JAMA Oncology
|
August 21, 2025
Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial
Jennifer A Ligibel, Karla V Ballman, Linda McCall, et al.
JAMA
|
June 6, 2022
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial
Ethan Basch, Deborah Schrag, Sydney Henson, et al.
JAMA Oncology
|
January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial
Cynthia X Ma, Vera J Suman, Souzan Sanati, et al.
Page
of 16